Cancer cells often rely on the DDR pathway to survive DNA damage caused by rapid cell division or external factors like chemotherapy and radiation. ATR inhibitors interfere with this pathway by blocking ATR kinase activity, preventing the activation of downstream proteins involved in DNA repair. This results in the accumulation of DNA damage, ultimately leading to apoptotic cell death or senescence in cancer cells.
